InvestorsHub Logo
Followers 10
Posts 1244
Boards Moderated 0
Alias Born 10/12/2012

Re: None

Saturday, 04/19/2014 5:52:03 PM

Saturday, April 19, 2014 5:52:03 PM

Post# of 30990
Anti-inflammatory effects of RCP006--worth reposting.

"The Roskamp Institute is interested in finding new treatments for the diseases of aging associated with chronic inflammation. In this respect Roskamp Institute scientists are examining the properties of RCP006 whose active ingredient is anatabine. In further studies of NF-KB activity and anatabine's ability to decrease it, we see that LPS induced NF-KB activation in human white blood cells is decreased at dose equivalents to aspirin or celebrex (which is toxic at these doses)."

Article at:
http://www.rfdn.org/inflammaging3.html
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.